Recently, we used the SGRM CORT108297 to target GR in combination with the β-catenin inhibitor MSAB in DTX-resistant PCa cells, observing that this combination significantly enhanced cellular responses to DTX [25]. This evidence concerns the gene NR3C1 and posterior cortical atrophy.